ReviewCureus2026
Chiari Malformation Type I: A Review of Pathophysiology, Cerebrospinal Fluid Flow Dynamics, Diagnosis, Surgical Management, and Its Relationship to Syringomyelia.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep Learning for Brain MRI Artifact Correction: Current Challenges and Future Directions.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chiari malformation type I (CM-I) is a neurological disorder characterized by the herniation of the cerebellar tonsils through the foramen magnum, resulting in the obstruction of cerebrospinal fluid (CSF) flow and the compression of the brainstem and upper cervical spinal cord. These disturbances contribute to symptoms such as headaches exacerbated by Valsalva maneuvers, dizziness, neck pain, muscle weakness, sensory disturbances, and coordination difficulties. This review provides an overview of the pathophysiology of CM-I, the role of disrupted CSF dynamics, and diagnostic approaches including magnetic resonance imaging (MRI) and cine MRI. Moreover, this review provides current management strategies ranging from conservative therapy to posterior fossa decompression. Additionally, the relationship between CM-I and syringomyelia is examined, emphasizing how altered CSF flow contributes to syrinx formation. Greater understanding of these mechanisms supports earlier diagnosis and more targeted treatment, highlighting the need for continued research into neuroprotective therapies that enhance long-term outcomes and quality of life for patients with CM-I.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.